NCT02757300

Brief Summary

After approval of the Institutional Review Board and written patient´s informed consent patients with indication for surgery of the sinuses were randomly assigned to one of the two study groups. After standardized anaesthetic management and PONV prophylaxis routinely applied the patients were screened for mucosal injury on second postoperative day. Furthermore, the amount of analgetic and anti-emetic drugs and the severity of pain and PONV were recorded throughout the hospital stay.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2016

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2016

Completed
12 days until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 2, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

September 1, 2022

Status Verified

August 1, 2022

Enrollment Period

10 months

First QC Date

April 19, 2016

Last Update Submit

August 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence and severity of mucosal injury

    Incidence and severity of mucosal injury evaluated by NRS-Scores and a colleague of the ENT department blinded to intra-operative management

    Second postoperative day

Study Arms (2)

Hypopharyngeal packing

EXPERIMENTAL

Patients with indication for surgery of the sinuses were randomly assigned to one of the two study groups. After standardized anaesthetic management and PONV prophylaxis routinely applied the patients were screened for mucosal injury on second postoperative day. Furthermore, the amount of analgetic and anti-emetic drugs and the severity of pain and PONV were recorded throughout the hospital stay.

Device: Hypopharyngeal packing

Without hypopharyngeal packing

ACTIVE COMPARATOR

Patients with indication for surgery of the sinuses were randomly assigned to one of the two study groups. After standardized anaesthetic management and PONV prophylaxis routinely applied the patients were screened for mucosal injury on second postoperative day. Furthermore, the amount of analgetic and anti-emetic drugs and the severity of pain and PONV were recorded throughout the hospital stay.

Device: Without Hypopharyngeal packing

Interventions

After introduction and orotracheal intubation a hypopharyngeal packing soaked with Chlorhexidinbis (D-gluconat) is placed.

Hypopharyngeal packing

After introduction and orotracheal intubation the patient will pass the operation without hypopharyngeal packing with a short tip coming out the mouth to imitate a packing.

Without hypopharyngeal packing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Surgery of the sinuses
  • Patients over 18 years of age
  • Duration of surgery \> 1h

You may not qualify if:

  • Refusal of the patient
  • Patients under 18 years of age
  • Chemotherapy with antiemetic medication
  • Combined surgery (for example tonsillectomie and sinus surgery)
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pharyngitis

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Martin Beiderlinden, PD

    Marienhospital Osnabrück

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
P.D. Dr. med. M. Beiderlinden

Study Record Dates

First Submitted

April 19, 2016

First Posted

May 2, 2016

Study Start

May 1, 2016

Primary Completion

March 1, 2017

Study Completion

July 1, 2018

Last Updated

September 1, 2022

Record last verified: 2022-08